Refine Search
...spearheaded by U.N. agencies to prevent and treat the epidemic. Senior executives from Abbott Laboratories Inc., Bristol-Myers Squibb, GlaxoSmithKline, Hoffman-La Roche, Pfizer and Germany's Boehringer Ingelheim pledged to accelerate price...
...headquarters. Software company SAS provides take-home dinners and a hairstylist three times a week. Drug maker Bristol-Myers Squibb Co. sends baby formula to employees' homes for a newborn's first year. These and other perks make the companies...
...joined the three cases because they involve drugs widely used by Americans aged 50 and older. One lawsuit charges Bristol-Myers Squibb Co. of illegally maintaining a monopoly on BuSpar, an anti-anxiety drug. Another alleges Schering-Plough...
...said Dr. Eric Topol of Cleveland Clinic. He helped conduct the research and also works as a consultant for Bristol-Myers Squibb Co. and Sanofi-Synthelabo, which market the drug and paid for the study. Dr. Robert Bonow, president of...
...the Food and Drug Administration approved in 2004. The key ingredient in the breast cancer drug Taxol owned by Bristol-Myers Squibb Co. is taken from the bark of the yew tree and Wyeth's kidney transplant drug Rapamune comes from Easter Island...
...Orlando of the American College of Cardiology. It was financed by Plavix's makers, Sanofi-Synthelabo and Bristol-Myers Squibb. It was conducted on 12,562 patients in 28 countries who had acute coronary syndrome. These are patients with...
...gets into the act. On Monday, Armstrong and his 17-month-old son, Luke, shot a 60-second commercial for Bristol-Myers Squibb. The pharmaceutical company makes the chemotherapy drugs that helped Armstrong win his battle against cancer...
...eye," Mark Heywood of the group Treatment Action Campaign said of the companies, which include giants Merck, Bristol-Myers Squibb, GlaxoSmithKline and Boehringer Ingelheim. "And I think it will embolden people in developing countries around...
...number of brands in the food business in an effort to boost profits. Procter is buying the Clairol business from Bristol-Myers Squibb Co., which put it up for sale last September so it can focus on its drug business. Clairol is a world leader...
...crisis wasn't the only reason investors sold. A handful of reduced earnings forecasts -- the biggest from Bristol-Myers Squibb -- provided an inauspicious start to the first-quarter earnings season and led some investors to question whether...